Table 3.
Topic | Comment | References |
---|---|---|
General | Higher rates in • Thyroid cancer with central lymph node dissection • Graves’ disease Risk mitigation • Awareness • Preoperative screening of parathyroid function • Vitamin D status |
102, 118, 119 |
Comorbidities | Obesity Gastrointestinal malabsorption, for example, post gastric bypass, severe IBDRisk mitigation • Awareness |
118 |
Primary exploration vs repeated surgery | Higher risk in • case of repeated surgeryRisk mitigation • critical assessment for additional/repeated surgeries |
102 |
Combined thyroid and parathyroid surgery | Thyroid and parathyroid disease often co-exist but unnoticed if not specifically evaluated Risk mitigation • preoperative evaluation for elective thyroid surgery must include parathyroid function (and vice versa) |
102 |
Total thyroidectomy vs less extensive surgery | Risk bilateral surgery > risk unilateral surgery Risk mitigation • individualized surgical strategy |
120 |
Bilateral cervical exploration in parathyroid disease | Risk bilateral exploration > focused PTX Risk mitigation • preoperative localization (ultrasound and nuclear medicine techniques) • exclusion of FHH (no surgery, see Q1, Primary Hyperparathyroidism) |
121 |
FHH, familial hypocalciuric hypercalcemia; HypoPT, chronic hypoparathyroidism; PHPT, primary hyperparathyroidism; PTX, parathyroidectomy.